Lansoprazole, amoxicillin, clarithromycin (DrugBank: Lansoprazole, Amoxicillin, Clarithromycin)
7 diseases告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
63 | 特発性血小板減少性紫斑病 | 0 |
71 | 特発性大腿骨頭壊死症 | 0 |
85 | 特発性間質性肺炎 | 0 |
98 | 好酸球性消化管疾患 | 0 |
166 | 弾性線維性仮性黄色腫 | 0 |
222 | 一次性ネフローゼ症候群 | 1 |
299 | 嚢胞性線維症 | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00983034 (ClinicalTrials.gov) | March 2006 | 21/9/2009 | The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous Nephropathy | Prospective Study of the Effects of Helicobacter Pylori Eradication on Renal Functions and Proteinuria in Patients With Membranous Nephropathy | Nephrotic Syndrome;Glomerulonephritis;Membranous Nephropathy | Drug: lansoprazole, amoxicillin, clarithromycin | Istanbul University | NULL | Completed | 18 Years | 70 Years | Both | 70 | N/A | Turkey |